DENND1B Inhibitors are a class of chemicals that can directly or indirectly inhibit the functional activity of DENND1B by influencing the cellular processes or signaling pathways in which it is involved. These inhibitors primarily target the PI3K-Akt and MAPK pathways, where DENND1B is known to play roles. For instance, LY294002 and Wortmannin are PI3K inhibitors that disrupt the PI3K-Akt pathway, impeding the normal functioning of DENND1B. Rapamycin, an mTOR inhibitor, also disrupts the PI3K-Akt pathway and can result in the decreased functional activity of DENND1B. Moreover, Akti-1/2, a specific Akt1/2 inhibitor, directly affects the PI3K-Akt signaling pathway, leading to the decreased functional activity of DENND1B.
In addition to the PI3K-Akt pathway, DENND1B Inhibitors such as SB203580, PD98059, SP600125, and U0126 target the MAPK pathway. SB203580, a potent inhibitor of p38 MAPK, can indirectly inhibit the functional activity of DENND1Bby impeding this pathway. PD98059 and U0126, inhibitors of MEK, can act as indirect inhibitors of DENND1B by inhibiting MEK, a component upstream of ERK in the MAPK pathway. SP600125, an inhibitor of JNK, a key component of the MAPK pathway, can decrease the functional activity of DENND1B. Besides these, some DENND1B Inhibitors such as PP2, Y-27632, KN-93, and Genistein target other cellular processes or signaling pathways that DENND1B might be involved in. PP2, an inhibitor of Src family kinases, and Y-27632, a potent inhibitor of ROCK, can lead to the decreased functional activity of DENND1B if it is involved in the same cellular processes as these kinases. KN-93 inhibits CaMKII, which impacts multiple signaling pathways and can decrease the functional activity of DENND1B if it participates in any of these pathways. Genistein, a tyrosine kinase inhibitor, can decrease the functional activity of DENND1B participates in tyrosine kinase-related signaling. Thus, DENND1B Inhibitors work through a variety of mechanisms to inhibit the functional activity of DENND1B.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that obstructs the PI3K-Akt signaling pathway. As DENND1B is known to be involved in this pathway, the inhibition of PI3K can directly interfere with the pathway’s normal functioning and subsequently lead to the reduction in the functional activity of DENND1B. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is also a PI3K inhibitor that interferes with the PI3K-Akt pathway. By inhibiting PI3K, it disrupts the pathway's activity and can subsequently decrease the functional activity of DENND1B. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a potent inhibitor of p38 MAPK. Given that DENND1B is involved in the p38 MAPK pathway, this compound can indirectly inhibit the functional activity of DENND1B by impeding this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is an inhibitor of MEK, which is upstream of ERK in the MAPK pathway. By inhibiting MEK, PD98059 can act as an indirect inhibitor of DENND1B, which is known to participate in this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin is an mTOR inhibitor, which plays a key role in the PI3K-Akt pathway. By inhibiting mTOR, the PI3K-Akt pathway can be disrupted, which can result in the decreased functional activity of DENND1B. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, a key component of the MAPK pathway. By inhibiting JNK, this compound can decrease the functional activity of DENND1B if it is involved in this pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 is an inhibitor of Src family kinases. If DENND1B is involved in the same cellular processes as these kinases, its functional activity can be decreased by PP2. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $204.00 $265.00 | 29 | |
Akti-1/2 is a selective Akt1/2 inhibitor. Given that DENND1B is involved in the PI3K-Akt signaling pathway, inhibiting Akt could directly result in the decreased functional activity of DENND1B. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 is a potent inhibitor of ROCK. If DENND1B is involved in the same cellular processes as ROCK, this compound can lead to the decreased functional activity of DENND1B. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
KN-93 inhibits CaMKII, which impacts multiple signaling pathways. If DENND1B participates in any of these pathways, its functional activity can be decreased by KN-93. | ||||||